Lexicon Pharmaceuticals
LXRX
#6255
Rank
S$1.31 B
Marketcap
S$2.96
Share price
-1.28%
Change (1 day)
114.78%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2026 (TTM): S-$0.09026

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is S-$0.08973. In 2025 the company made an earnings per share (EPS) of S-$0.18 an increase over its 2024 EPS that were of S-$0.82.

EPS history for Lexicon Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$0.09026-49.7%
2025S-$0.18-78.13%
2024S-$0.82-20%
2023S-$1.0331.15%
2022S-$0.78-0%
2021S-$0.7810.91%
2020S-$0.70-145.08%
2019S$1.56-206.09%
2018S-$1.47-5.74%
2017S-$1.56-10.95%
2016S-$1.762640%
2015S-$0.06409-96.34%
2014S-$1.75-2.53%
2013S-$1.79-9.09%
2012S-$1.97

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
S$23.35-26,128.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
S$7.09-8,000.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
S$54.51-60,857.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
S-$7.83 8,628.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
S$10.05-11,300.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
S-$0.02564-71.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
S-$0.96 971.43%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$1.79-2,100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
S-$2,098 2,338,114.29%๐Ÿ‡บ๐Ÿ‡ธ USA